We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Thermo Extends SARS-CoV-2 Program to Support Research on New Virus Strains

Product News   Jan 14, 2021

 
Thermo Extends SARS-CoV-2 Program to Support Research on New Virus Strains
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Moderna’s COVID-19 Vaccine Retains Neutralizing Activity Against Variants

Product News

Moderna Inc today announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2.

READ MORE

Rapid, Cost-Efficient Sample Processing in Workflows

Product News

Novel RHINOstic™ swab collection device and LabElite® DeCapper increase sample throughput and consistency compared to manual methods.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE